Can this agreement be signed electronically?

Yes. Electronic signatures are enforceable under the ESIGN Act (15 U.S.C. ch. 96) and under UETA in most states, provided intent, consent, attribution, and record retention requirements are met.

When is notarization required?

Notarization depends on state formalities and the document's use. Certain transactions or witness-proofing needs may require notary acknowledgment or RON; verify state law and document purpose.

Does HIPAA apply to this agreement?

If the agreement collects or transmits protected health information, HIPAA applies; include permissible-disclosure language and ensure business associate agreements as needed.

How do I revoke or amend the agreement?

Specify amendment and revocation procedures in the contract, including notice periods. For consumer-facing agreements, include procedures to withdraw electronic consent per 15 U.S.C. §7001(c).

What if a signer lacks capacity?

Include representative or guardian signature provisions and require evidence of authority; consider notarization or additional authentication for substituted decision-makers.

How should executed agreements be stored?

Store signed copies and audit trails in encrypted storage with access controls, retain per applicable retention rules (HIPAA 45 CFR §164.530(j), IRS IRC §6501(a)), and document retention policies.

Electronic Signature
Templates
Legal
Legal Disease Agreement

Legal Disease Agreement

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

LEGAL DISEASE AGREEMENT

This Legal Disease Agreement ("Agreement") is made as of Effective Date: between Party A Name: (check entity type: Individual Corporation LLC Other) and Party B Name: (check entity type: Individual Corporation LLC Other).

RECITALS

WHEREAS, Party A and Party B desire to set forth their respective duties, responsibilities and risk allocation with respect to infectious disease exposure, prevention, reporting and response in connection with activities conducted by or on behalf of the parties; and

WHEREAS, the parties intend by this Agreement to reduce the risk of transmission of Covered Disease(s) during the term hereof and to allocate responsibility for mitigation, notification, costs, and liabilities arising from exposure, infection, or transmission; and

WHEREAS, the parties acknowledge that the obligations herein supplement, and do not relieve either party of, its obligations under applicable law and applicable public health orders.

NOW, THEREFORE, in consideration of the mutual covenants contained herein and other good and valuable consideration, the parties agree as follows.

1. DEFINITIONS

1.1 "Covered Disease" means any communicable disease specified by the parties or declared by a public health authority as a public health threat. Covered Disease(s):

1.2 "Exposure" means an event or circumstance in which an individual has a level of contact with an Infected Individual that, in the judgment of a qualified health professional, could reasonably result in transmission.

1.3 "Infectious Disease Protocols" means the written procedures, testing requirements, personal protective equipment requirements, reporting requirements and isolation or quarantine measures described in this Agreement and in the Safety Plan submitted by a party.

2. REPRESENTATIONS AND WARRANTIES

2.1 Each party represents and warrants that it has full authority to enter into this Agreement, that the execution and performance of this Agreement will not violate any other agreement to which it is a party, and that it will comply with all applicable laws and public health directives in performing its obligations hereunder.

2.2 Each party warrants that, to the best of its knowledge, at the time of performance of any in-person activity under this Agreement, its personnel will not be knowingly infected with a Covered Disease and will not have had an Exposure within the time period required by the applicable Infectious Disease Protocols.

3. PREVENTION AND MITIGATION

3.1 Each party shall adopt and maintain reasonable Infectious Disease Protocols, including but not limited to symptom screening, physical distancing, use of personal protective equipment, sanitation procedures, and limitations on occupancy. The party responsible for maintaining a written Safety Plan shall attach or describe that plan below.

Safety Plan / Protocol Summary

3.2 Parties shall ensure that personnel adhere to the Safety Plan while on premises or while performing services. Failure to follow the Safety Plan shall constitute a breach of this Agreement and may justify immediate removal of non-compliant personnel.

4. TESTING, REPORTING AND ISOLATION

4.1 If a party or any of its personnel tests positive for a Covered Disease or reasonably suspects infection, that party shall notify the other party in writing within business days of receipt of test results or knowledge of symptoms. Notification shall include the date of test or symptom onset and the identity of potentially exposed personnel to the extent known and permitted by privacy laws.

4.2 The notifying party shall take all reasonable steps to isolate affected personnel, cooperate with contact tracing, and comply with any applicable public health directions. Costs of testing for contacts required by either party's protocols shall be borne by:

5. INDEMNIFICATION AND COST ALLOCATION

5.1 Each party (the "Indemnifying Party") shall indemnify, defend and hold harmless the other party and its affiliates, officers, directors, employees and agents (collectively, the "Indemnified Parties") from and against all third-party claims, liabilities, damages, losses and expenses, including reasonable attorneys' fees, arising out of the Indemnifying Party's breach of this Agreement or its negligent acts or omissions resulting in Exposure or transmission of a Covered Disease.

5.2 Notwithstanding the foregoing, each party's indemnification obligations shall be subject to the indemnified party providing prompt written notice of the claim, reasonable cooperation in the defense, and the indemnifying party's right to assume control of the defense.

6. INSURANCE

6.1 Each party shall maintain commercial general liability and, where applicable, workers' compensation and employer's liability insurance with minimum coverage limits of:

Minimum Liability Coverage Amount

6.2 Each party shall furnish certificates evidencing such insurance upon request and shall provide notice to the other party of any cancellation or material change in coverage.

7. CONFIDENTIALITY OF HEALTH INFORMATION

7.1 Parties shall not disclose individually identifying health information obtained under this Agreement except as required by applicable law, public health reporting obligations, or with the individual's written consent. Any permissible disclosure shall be limited to the minimum information necessary to comply with the legal obligation.

8. LIMITATION OF LIABILITY

8.1 Except for liability arising from a party's gross negligence, willful misconduct, or its indemnification obligations under Section 5, neither party shall be liable to the other for special, incidental, indirect or consequential damages, including lost profits, regardless of the form of action, even if advised of the possibility of such damages.

9. FORCE MAJEURE

9.1 A party shall be excused from performance to the extent that performance is prevented by a force majeure event, including an epidemic, pandemic, government-imposed restriction, or other public health emergency. The affected party shall promptly notify the other party and use commercially reasonable efforts to mitigate the impact of the event.

10. TERM; TERMINATION

10.1 This Agreement shall commence on the Effective Date and continue until terminated by either party upon thirty (30) days' prior written notice, unless earlier terminated for material breach as set forth herein.

10.2 If a party materially breaches its obligations with respect to Infectious Disease Protocols and fails to cure within seven (7) days after written notice, the non-breaching party may terminate this Agreement immediately.

11. NOTICES

All notices required or permitted under this Agreement shall be in writing and delivered to the addresses below by hand, nationally recognized overnight carrier, or certified mail (return receipt requested). Notices are effective upon receipt.

Party A Contact Name Party A Contact Address Party A Contact Phone / Email Party B Contact Name Party B Contact Address Party B Contact Phone / Email

12. AMENDMENTS; WAIVER; COUNTERPARTS

12.1 This Agreement may be amended only by a written instrument signed by both parties. No course of dealing or failure to enforce any provision shall constitute a waiver.

12.2 This Agreement may be executed in counterparts, each of which shall be deemed an original, and all of which together shall constitute one and the same instrument.

13. GOVERNING LAW; ENTIRE AGREEMENT; SEVERABILITY

13.1 Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the jurisdiction selected by the parties:

13.2 Entire Agreement. This Agreement constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior and contemporaneous agreements and understandings, whether written or oral.

13.3 Severability. If any provision of this Agreement is held to be invalid or unenforceable, the remaining provisions shall remain in full force and effect.

MISCELLANEOUS PROVISIONS

14.1 Assignment. Neither party may assign its rights or delegate its obligations under this Agreement without the prior written consent of the other party, except to an affiliate or successor by merger or acquisition.

14.2 Remedies. The rights and remedies provided in this Agreement are cumulative and in addition to any other rights or remedies available at law or in equity.

Party A:

By:

Date:

Party B:

By:

Date:

What the Legal Disease Agreement Is

A Legal Disease Agreement is a written contract that defines obligations, reporting, confidentiality, and liability between parties when disease exposure, transmission risk, or related medical conditions are relevant to a relationship. Typical uses include workplace exposure protocols, patient-provider disclosure terms, facility access rules, and vendor obligations during outbreaks. The agreement allocates responsibilities for notification, testing, treatment costs, workplace accommodations, indemnities, and data handling. It may reference public-health requirements and incorporate privacy protections for medical information while specifying dispute-resolution, governing law, and signature and notarization expectations.

Why a Legal Disease Agreement Matters

A clear agreement reduces legal uncertainty by documenting obligations, consent to medical data use, and allocation of financial and operational risk. It supports compliance with ESIGN (15 U.S.C. ch. 96) and UETA where electronic signatures are used, and it clarifies confidentiality expectations under HIPAA when protected health information is involved.

Who typically prepares or signs this agreement

The Legal Disease Agreement is used by employers, healthcare providers, educational institutions, contractors, and facility operators whenever disease exposure creates legal or operational obligations.

Employers and HR teams responsible for workplace safety and reasonable accommodations.
Healthcare providers and clinics handling patient notification, treatment, and data-sharing.
Educational institutions managing student and staff health protocols and authorizations.

Parties usually include a named responsible officer for notifications and a designated privacy contact for handling medical information and consent revocations.

Core elements to include in the agreement

A professional Legal Disease Agreement should combine clear definitions, reporting duties, confidentiality and data-handling rules, indemnity and insurance terms, signature and notarization blocks, and dispute-resolution methods.

Definitions

Define 'disease', 'exposure', 'close contact', and trigger events precisely to avoid ambiguity in enforcement and reporting.

Notification Duties

State required notification timelines, responsible parties, and required content of notices including who must be informed and how.

Medical Information Handling

Specify permitted uses of medical data, storage safeguards, access controls, and HIPAA-consistent handling where PHI is involved.

Liability & Indemnity

Allocate responsibility for costs, testing, treatment, and third-party claims; include insurance requirements and limits.

Signature & Authentication

Include signature blocks, notarization and witness requirements, and acceptable eSignature methods and authentication strength.

Governing Law and Dispute Resolution

Specify governing state law, arbitration or court venue, and how amendments will be handled.

Step-by-step: completing the agreement

Follow this sequence to create a legally sound and operationally effective Legal Disease Agreement.

01

Draft terms: Define triggers, duties, and scope clearly.
02

Add privacy language: Include HIPAA-consistent handling if PHI is collected.
03

Choose signatures: Select eSignature level and notarization requirements.
04

Distribute copies: Share executed copies and retain records securely.

How to configure an online signing workflow

Set up a consistent digital workflow so all signers receive the correct fields, authentication, and record retention automatically.

Field	Configuration
Signer Order	Define sequential or parallel routing to control execution order.
Authentication	Select email link, SMS code, or stronger methods for signer verification.
Conditional Fields	Show additional sections only when triggered by specific answers.
Audit Trail	Capture IP, timestamp, and action log for each signer.

Typical submission and processing flow

The process below summarizes where the agreement goes after completion and how parties are notified.

Upload: Sender uploads the completed draft for review.
Assign Fields: Place signature, date, and conditional fields for each party.
Send for Signature: Recipients receive an email or link to sign electronically.
Archive: Signed copy and audit trail are saved for retention.

Digital signing and technical requirements

Decide upfront whether the agreement will be signed electronically, in-person, or require notarization, and select platform features accordingly.

Formats: PDF, Word DOCX, or HTML accepted.
Integrations: Connect to Google Workspace, Microsoft 365, or NetSuite.
Auth Options: Email, SMS, KBA, or advanced signer authentication.

Ensure the chosen eSignature provider supports audit trails, retention, and any industry compliance (for example, HIPAA BAA) required by your organization.

eSignature vendor comparison for executing the agreement

Budget and compliance needs vary; this table summarizes starting prices and select features for common providers, with signNow listed first per platform comparison requirements.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial	Varies by vendor	Varies by vendor	Varies by vendor	Varies by vendor
Bulk Send	Yes (premium tiers)	Yes	Yes	Yes	Yes
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No

Common timelines and processing expectations

Establish internal and external deadlines so parties meet notification, review, and archival obligations consistently.

Notification Deadline:

Specify hours or days (for example, 'within 48 hours') as a clear contractual obligation

Internal Review:

Allow 5–10 business days for legal and compliance review before execution

Signature Window:

Set a signing period, commonly 7–14 days, to close administrative loops

RON Record Retention:

Retain audio-video notarization records for 5–10 years as required by many states

Amendment Notice:

Provide a defined notice period (30 days typical) for material amendments

Common mistakes to avoid when preparing the agreement

Using vague definitions for 'exposure' that create enforcement disputes and inconsistent application across incidents.
Failing to specify how medical data will be collected, stored, and shared, which increases HIPAA and privacy risk.
Omitting signature authentication levels or notarization requirements, leading to questions about enforceability.
Neglecting state-specific formalities — witness counts or notarization rules can vary and affect admissibility.

Essential information and fields to capture

Party names: Full legal names

Contact info: Address, phone, email

Effective date: MM/DD/YYYY

Reporting terms: Notification deadlines

Privacy contact: HIPAA/privacy officer

Signatures: Signature, printed name, title

Potential legal and operational risks

Breach consequences: Contract damages

Regulatory fines: HIPAA penalties

Insurance denial: Coverage disputes

Invalidation: Formality defects

Reputational harm: Public disclosure risk

Litigation costs: Attorney fees

Real-world examples of similar document use

Below are two brief examples showing how organizations apply digital signing and compliance practices to health-related agreements.

Fertility Centers of Illinois

A medical clinic needed secure patient consent forms for sensitive procedures

The team adopted structured consent language and strict PHI handling
The organization highlighted improved record tracking and compliance with privacy requirements while maintaining signed audit trails.

Martin Properties

A property manager required tenant health-disclosure addenda during a local outbreak

The manager used clear notification triggers and return-to-occupancy conditions
The process reduced in-person meetings and ensured consistent, dated records for each tenant interaction.

Practical tips for accurate completion

Adopt clear drafting and execution practices to reduce disputes and make the agreement operationally useful.

Use precise definitions

Avoid colloquial terms and define all clinical and operational phrases so parties have a common baseline for action and enforcement.

Document decision makers

Name the responsible officer for notifications and the privacy contact; include contact information and escalation procedures.

Confirm consent process

For consumer-facing agreements, document the consumer's consent to electronic records per 15 U.S.C. §7001(c) and provide paper-option procedures.

Retain audit logs

Keep signed copies, audit trails, and any RON recordings per state retention requirements to support later legal review.

Frequently asked questions

Answers to common legal and practical questions about executing and enforcing a Legal Disease Agreement.

Need help? Contact support

Can this agreement be signed electronically?
Yes. Electronic signatures are enforceable under the ESIGN Act (15 U.S.C. ch. 96) and under UETA in most states, provided intent, consent, attribution, and record retention requirements are met.
When is notarization required?
Notarization depends on state formalities and the document's use. Certain transactions or witness-proofing needs may require notary acknowledgment or RON; verify state law and document purpose.
Does HIPAA apply to this agreement?
If the agreement collects or transmits protected health information, HIPAA applies; include permissible-disclosure language and ensure business associate agreements as needed.
How do I revoke or amend the agreement?
Specify amendment and revocation procedures in the contract, including notice periods. For consumer-facing agreements, include procedures to withdraw electronic consent per 15 U.S.C. §7001(c).
What if a signer lacks capacity?
Include representative or guardian signature provisions and require evidence of authority; consider notarization or additional authentication for substituted decision-makers.
How should executed agreements be stored?
Store signed copies and audit trails in encrypted storage with access controls, retain per applicable retention rules (HIPAA 45 CFR §164.530(j), IRS IRC §6501(a)), and document retention policies.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now